| Accession Number: | 0001209191-23-010583 |
| Date: | 2023-02-06 |
| Issuer: | VERA THERAPEUTICS, INC. (VERA) |
| Original Submission Date: | 2023-02-08 |
GRANT SEAN
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE, CA 94005
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| CLASS A COMMON STOCK | 2023-02-06 | P | 14,285 | a | $7.00 | 49,933 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | the reporting person's original form 4 contained a typographical error on the transaction date. |
| f2 | shares purchased by the reporting person in the issuer's follow-on offering, which closed on february 6, 2023. the purchase price is the offering price. |
| f3 | includes 380 shares acquired under the issuer's employee stock purchase plan on september 13, 2022. |
